Sun Pharma Board to Consider Raising up to INR 15,000 Crore via NCDs
Sun Pharmaceutical Industries Ltd 路 Intimation 路 08 Oct 2026, 2:09 am
Sun Pharma Board to Consider Raising up to INR 15,000 Crore via NCDs Sun Pharmaceutical Industries Limited has scheduled a Board of Directors meeting on 12th Oct'26 to consider and approve the issuance of listed, rated, unsecured, redeemable non-convertible debentures (NCDs). The planned fundraise will be executed in one or more tranches on a private placement basis for an aggregate amount not exceeding INR 15,000 Crore.
Original exchange filing (PDF)
More announcements from Sun Pharmaceutical Industries Ltd
- Intimation of Schedule of Analyst/Institutional Investor Meeting 路 05 Nov 2026
- Q2FY27 Earnings Call Transcript 路 05 Nov 2026
- Clarification regarding news report relating to the Company''s Assam facility 路 03 Nov 2026
- The Exchange has sought clarification from Sun Pharmaceutical Industries Ltd on November 2, 2026, with reference to news appeared in https://www.thehindu.com/ dated October 30, 2026 quoting .... 路 02 Nov 2026
- Completion and results of postal ballot dated 01 October 2026 路 01 Nov 2026
- Q2FY27- Investor Call Audio Recording 路 31 Oct 2026
- Board Meeting Outcome - Conclusion 路 30 Oct 2026
- Unaudited Financial Results for the quarter and half year ended 30 September 2026 路 30 Oct 2026
